Literature DB >> 387569

Degradation of even-numbered reduced and non-reduced hyaluronate oligosaccharides with D-glucuronic acid or N-acetyl-D-glucosamine as non-reducing terminal by chondroitin ABC and AC lyases.

H P Ulrich, U Klein, K von Figura.   

Abstract

Chondroitin ABC and AC lyases split hexosaminidic linkages in galactosaminoglycans and hyaluronic acid. Even-numbered oligosaccharides from hyaluronic acid with either D-glucuronic acid or N-acetylglucosamine in non-reducing position were used, prior to and after reduction with sodium borohydride, as substrates for chondroitin ABC and AC lyases. These substrates allowed elucidation of the effects of the nearest neighborhood of the bond to be split on the action of the enzymes. The results indicate that chondroitin ABC lyase acts strictly as an endolyase towards hyaluronate and requires the presence of a disaccharide in both reducing and non-reducing positions of the endohexosaminidic bond to be split. None of the hexosaminidic bonds of the tetrasaccharide GlcNAc-GlcUA-GlcNAc-GlcUA is split by chondroitin ABC lyase. In contrast chondroitin AC lyase acts also as an exoglycosidase towards hyaluronate and recognizes only the amino sugar and the uronic acid residue that are linked via the hexosaminidic bond which is split. Thus, the N-acetylglucosamine and glucuronic acid residues at both ends of a tetrasaccharide with the structure GlcNAc-GlcUA-GlcNAc-GlcUA are liberated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 387569     DOI: 10.1515/bchm2.1979.360.2.1457

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  2 in total

Review 1.  Polysaccharide lyases.

Authors:  R J Linhardt; P M Galliher; C L Cooney
Journal:  Appl Biochem Biotechnol       Date:  1986-04       Impact factor: 2.926

2.  Identification of the reaction products of the purified hyaluronidase from stonefish (Synanceja horrida) venom.

Authors:  K Sugahara; S Yamada; M Sugiura; K Takeda; R Yuen; H E Khoo; C H Poh
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.